Financials Scandinavian Medical Solutions A/S

Equities

SMSMED

DK0061675006

Advanced Medical Equipment & Technology

Delayed Nasdaq Copenhagen 07:47:27 2024-06-17 EDT 5-day change 1st Jan Change
6.42 DKK +0.31% Intraday chart for Scandinavian Medical Solutions A/S -3.31% -13.48%

Valuation

Fiscal Period: September 2022 2023
Capitalization 1 122.6 281.4
Enterprise Value (EV) 1 94.97 302
P/E ratio 10.8 x 23 x
Yield - -
Capitalization / Revenue 1.11 x 1.47 x
EV / Revenue 0.86 x 1.58 x
EV / EBITDA 6.19 x 14.3 x
EV / FCF -3,127,790 x -6,270,081 x
FCF Yield -0% -0%
Price to Book 1.97 x 3.78 x
Nbr of stocks (in thousands) 27,250 27,317
Reference price 2 4.500 10.30
Announcement Date 11/21/22 11/20/23
1DKK in Million2DKK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2020 2021 2022 2023
Net sales 1 41.95 71.64 110.5 191.2
EBITDA 1 5.989 10.9 15.35 21.08
EBIT 1 5.965 10.87 14.74 16.63
Operating Margin 14.22% 15.18% 13.34% 8.7%
Earnings before Tax (EBT) 1 5.818 10.54 14.71 15.79
Net income 1 4.511 8.157 11.37 12.22
Net margin 10.75% 11.39% 10.29% 6.39%
EPS - - 0.4173 0.4478
Free Cash Flow - 2.328 -30.36 -48.17
FCF margin - 3.25% -27.47% -25.2%
FCF Conversion (EBITDA) - 21.36% - -
FCF Conversion (Net income) - 28.54% - -
Dividend per Share - - - -
Announcement Date 12/9/21 12/9/21 11/21/22 11/20/23
1DKK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: September 2020 2021 2022 2023
Net Debt 1 - - - 20.7
Net Cash position 1 10.6 25.4 27.7 -
Leverage (Debt/EBITDA) - - - 0.9812 x
Free Cash Flow - 2.33 -30.4 -48.2
ROE (net income / shareholders' equity) - 56.3% 26.4% 17.9%
ROA (Net income/ Total Assets) - 22% 12.2% 7.69%
Assets 1 - 37.03 93.06 158.9
Book Value Per Share - - 2.280 2.730
Cash Flow per Share - - 1.020 0.2900
Capex - - 13.8 40.8
Capex / Sales - - 12.45% 21.35%
Announcement Date 12/9/21 12/9/21 11/21/22 11/20/23
1DKK in Million
Estimates
  1. Stock Market
  2. Equities
  3. SMSMED Stock
  4. Financials Scandinavian Medical Solutions A/S